|BHF Translational Award
||Supports the pre-clinical development of new cardiovascular medicines and technologies so that they are attractive for follow-on funding: bridging the funding gap between promising innovations and the clinic
|CRUK Small Molecule Drug Discovery Project Awards
||Identify and characterise small molecule novel therapeutic targets and to identify and develop novel therapeutic entities for the benefit of cancer patients. New target identification & validation.
||One to three years, £300k
|GSK Discovery Partnership with Academia
||Integrated GSK-academic partnerships that can translate innovative research
||Six -12 months
||Multiple schemes which are updated regularly, ranging from small innovation vouchers to large, collaborative programmes. Usually industry-led.
|MRC Biomedical catalyst
||Early stage, small molecule, drug discovery. Will fund development of therapeutics.
||Up to three years, £3M
|Royal Society Innovation Award
||For scientists who wish to develop an already proven concept or prototype into a near-market product, ready for commercial exploitation.
||Up to two years, £250k
|Wellcome Trust Seed award
||Small, one-off grants to help researchers develop original and innovative ideas to a position where they would be able to be competitive for a larger award from the Wellcome Trust, or another source.
||Up to two years, £100k
|Worldwide Cancer Research
||Funding for basic and translational research into the causes, mechanisms, diagnosis, treatment or prevention of cancer
||12-36 months, £250k